Skip to content

Baltimore News Journal – Lifestyle

Author: AusperBio Therapeutics Inc.

AusperBio Announces First Patient Dosed in Clinical Study of Investigational HBV Candidate AHB-171

August 3, 2026

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.